Elanco to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference scheduled for Tuesday, January 14, 2025. Jeff Simmons, president and CEO, will represent the company and engage with analysts during a Q&A session at 3:00 p.m. PST (6:00 PM EST).

The event will be accessible through a live audio webcast on the 'Events and Presentations' section of Elanco's investor website, with a replay available for approximately 30 days following the presentation.

News Market Reaction – ELAN

+0.77%

+0.77% Session move

In the trading session that priced this news, ELAN gained 0.77%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GREENFIELD, Ind., Dec. 19, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 43^rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts at 3:00 p.m. PST (6:00 PM EST).

A live audio webcast will be available in the "Events and Presentations" section of Elanco's investor website. A replay will be available for approximately 30 days.

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose– all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com.

Investor Contact: Katy Grissom (317) 273-9284 kathryn.grissom@elancoah.com
Media Contact: Colleen Parr Dekker (317) 989-7011 colleen_parr_dekker@elancoah.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/elanco-to-participate-in-the-43rd-annual-jp-morgan-healthcare-conference-302336349.html

SOURCE Elanco Animal Health

FAQ

When is Elanco (ELAN) presenting at the 2025 J.P. Morgan Healthcare Conference?

Elanco (ELAN) is presenting at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 3:00 p.m. PST (6:00 PM EST).

How can investors access Elanco's (ELAN) J.P. Morgan Healthcare Conference presentation?

Investors can access Elanco's presentation through a live audio webcast available in the 'Events and Presentations' section of Elanco's investor website. A replay will be available for approximately 30 days after the event.

Who will represent Elanco (ELAN) at the 2025 J.P. Morgan Healthcare Conference?

Jeff Simmons, president and CEO of Elanco, will represent the company at the conference and respond to questions from analysts.

How long will the replay of Elanco's (ELAN) J.P. Morgan Conference presentation be available?

The replay of Elanco's presentation will be available for approximately 30 days following the event on the company's investor website.